Antibody Persistence Following Administration of a Hexavalent DTwP-IPV-HB-PRP~T Vaccine Versus Separate DTwP-HB-PRP~T and IPV Vaccines and Safety and Immunogenicity of a Booster Dose of DTwP-IPV-HB-PRP~T Administered With an MMR Vaccine in Healthy Infants in India.

Author: DhatiRavi Mandyam, KandukuriSreeramulu Reddy, KawadeAnand, KukianDarshna, LeclercqJulie, MangaruleSomnath, MiddeVenkata Jayanth, MitraMonjori, NoriegaFernando, PadmavathiInumarthi Vara, PalkarSonali, PalviKudyar, ShettyRanjitha, SiddaiahPrashanth, SinghRaghvendra, TripathiVirendranath, VargheseKucku

Paper Details 
Original Abstract of the Article :
BACKGROUND: Antibody persistence of a whole-cell pertussis-containing hexavalent vaccine (DTwP-IPV-HB-PRP~T) and its co- or sequential administration with measles, mumps, rubella (MMR) vaccine were evaluated. METHODS: Phase III, open-label, randomized, multicenter study in India. Healthy toddlers 1...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/37851978

データ提供:米国国立医学図書館(NLM)

Hexavalent Vaccine: A Multi-Layered Shield

[Hexavalent vaccines] offer protection against a range of [infectious diseases], like a multi-layered shield against the harsh desert environment. This study investigates the [antibody persistence] of a [hexavalent vaccine (DTwP-IPV-HB-PRP~T)] in [healthy infants] in [India]. It's like assessing the durability of a protective barrier against the elements, ensuring that it remains effective over time. The researchers also explored the [immunogenicity and safety] of a [booster dose] of this vaccine when administered with a [measles, mumps, rubella (MMR) vaccine].

A Durable and Safe Vaccine

The study showed that the [hexavalent vaccine] provided [long-lasting protection] and that the [booster dose] was both [safe and effective]. It's like reinforcing a protective barrier against the elements, ensuring that it remains strong and resilient.

Protecting Infants from Infectious Diseases

This research offers valuable insights into the safety and efficacy of [hexavalent vaccines] for infants, providing reassurance for parents seeking to protect their children from [infectious diseases]. It's like understanding the importance of a multi-layered shield in a harsh desert environment – ensuring that children are equipped with the best possible protection against potential threats.

Dr.Camel's Conclusion

This research reinforces the importance of [vaccination] for protecting infants from [infectious diseases]. The [hexavalent vaccine] offers a multi-layered shield, like a fortress in the desert, providing a strong defense against potential threats.

Date :
  1. Date Completed 2023-11-16
  2. Date Revised 2023-11-17
Further Info :

Pubmed ID

37851978

DOI: Digital Object Identifier

00006454-202312000-00030

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.